Technology
Research Publications
To download these publications click on the title
Posters
KODE™ Alteration of Cell Surface Characteristics
World’s first blood grouping sensitivity control: created with KODE™ technology
Water Dispersible Synthetic Glycolipids
The first example of the addition of peptide antigens to red blood cells using KODE technology
Development of synthetic peptidolipids
Journal Publications
- Harrison AL, Olsson ML, Brad Jones R, Ramkumar S, Sakac D, Binnington B, Henry S, Lingwood CA, Branch DR. A synthetic glotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconjugate 2010; 27: 515-524
- Heathcote D, Carroll T, Wang JJ, Flower R, Rodionov I, Tuzikov A, Bovin N & Henry S. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto erythrocytes. Transfusion 2010; 50: 635-641
- Henry S. Modification of red blood cells for laboratory quality control use. Current Opinion in Hematology 2009; 16(6):467-472
- Frame T, Carroll T, Korchagina E, Bovin N, Henry S. Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007; 47: 876-882
Published Conference Abstracts
- Oliver C, Blake D, Ferguson S, Bovin N, Henry S. Biotin-kodecytes - novel function-spacer-lipid (FSL) modified cells capable of being recovered from the circulation after 3 days. 35th FEBS Congress, June 2010, Sweden.
FEBS Journal 277 (Suppl. 1):50-51;2010 - Komarraju S, Chesla S, Bovin N, Henry S. Syphilis-kodecytes - novel function-spacer-lipid (FSL) modified red cells capable of sensitive and specific detection of syphilis antibodies. 35th FEBS Congress, June 2010, Sweden.
FEBS Journal 277 (Suppl. 1):97-98;2010 - Barr K, Diegel O, Parker S, Bovin N, Henry S. Function-Spacer-Lipid (FSL) constructs enable inkjet printing of blood group antigens. 35th FEBS Congress, June 2010, Sweden.
FEBS Journal 277 (Suppl. 1):235;2010 - Barr K, Diegel O, Parker S, Bovin N, Henry S. Function-Spacer-Lipid (FSL) constructs enable inkjet printing of blood group antigens. 35th FEBS Congress, June 2010, Sweden.
FEBS Journal 277 (Suppl. 1):235;2010 - Blake D, Lan A, Love D, Bovin N, Henry S. Fluorophore-kodecytes - fluorescent function-spacer-lipid (FSL) modified cells for in vitro and in vivo analyses. 35th FEBS Congress, June 2010, Sweden.
FEBS Journal 277 (Suppl. 1):199;2010 - Harrison, A.L., Kim, M., McCarthy, S.D.S., Henry, S., Lingwood, C.A, and Branch, D.R.: Synthetic Pk inhibits HIV-1 infection in vitro by two mechanisms. 19th Annual Canadian Conference of HIV/AIDS Research, Saskatoon, SK, May 2010.
Can J Infec Dis Med Microbiol 21(Suppl B):25B, 2010 - Harrison, A.L., McCarthy, S.D.S., Kim, M., Henry, S., Lingwood, C., and Branch, D.R.: Soluble globotriaosylceramide as a potential microbicide for the prevention of HIV-1 infection. 19th Annual Canadian Conference of HIV/AIDS Research, Saskatoon, SK, May 2010
Can J Infec Dis Med Microbiol 21(Suppl B):26B, 2010 - Branch DR, Harrison A, Sakac D, Lingwood C, Henry S. A synthetic, water dispersible glycolipid analogue of the Pk blood group antigen completely blocks HIV-1 infection. AABB 2008 Annual Meeting, October 2008,Montréal, Québec, Canada. Transfusion 2008; 48 (2S) Suppl.: 104A
- Henry S, Bovin N. The development of synthetic peptidolipids, glycolipids and other lipid-linked structures to create designer red cells. AABB 2008 Annual Meeting, October 2008, Montréal, Québec, Canada. Transfusion 2008; 48 (2S) Suppl.: 194A
- Hult AK, Frame T, Henry S, Olsson ML. Flow cytometry evaluation of red blood cells transformed with variable amounts of synthetic A and B glycolipids. ISBT Regional Congress, Macao SAR China, 2008. (P-322) Vox Sanguinis 2008; 95:Suppl 1, 180
- Heathcoate D, Flower R, Henry S. Development of novel alloantibody screening cells – the first example of the addition of peptide antigens to human red cells using KODE™ technology. ISBT Regional Congress, Macao SAR China, 2008. (P-303) Vox Sanguinis 2008; 95:Suppl 1, 174
- Flower R, Lin P-H, Heathcote D, Chan M, Teo D, Selkirk A, Shepherd R, Henry S. Insertion of KODE™ peptide constructs into red cell membranes: Creating artificial variant MNS blood group antigens. ISBT Regional Congress, Macao SAR China, 2008. (P-396) Vox Sanguinis 2008; 95:Suppl 1, 203-204
- Henry S. Water soluble synthetic glycolipids. Society for Glycobiology Meeting, Boston, USA, 2007 Glycobiology 2007; 17: 1267
- Frame T, Henry S, Mobley D, Chesla S. Attachment of synthetic carbohydrate antigens to red blood cells using KODE™ technology. AABB Meeting 2006, Miama, USA, 2006 Transfusion 2006; 46 (suppl. 9S): 32A
- Henry SM, Carroll T, Frame T. KODE™ technology allows the attachment of carbohydrate blood group antigens to red cells. XXIXth Congress of the International Society of Blood Transfusion, Cape Town, South Africa, 2006
Vox Sangunis 2006; 91 (suppl.3): 29 - Henry SM. KODE™ CAE: creating the world’s first ABO analytical control system. Annual Scientific Meeting, Australian and New Zealand Society of Blood Transfusion, Sydney, Australia, 2005
Transfusion Medicine 2006; 16: 217 - Henry SM. Engineering the surface of red cells with synthetic glycolipids (KODETM CAE) to create ABO analytical sensitivity controls and xeno-modified cells. 2nd International Symposium on ABO Incompatibility in Transplantation, Göteborg, Sweden, 2005
Xenotransplantation 2005; 12(5): 356
Due to copyright restrictions copies of the actual papers cannot be made available.
Abstracts
Top
KODE™ technology enabling the adherence of endometrial cells to an embryo